Cristina Popa 🦋

Nephrologist = kidney philosopher. History lover. Freethinker. #NephJC co-editor in chief; #kireports; #ERA; #ASN | E-migrated to🦋

[Cristina Popa 🦋 @NephroSeeker]

It began in 2021, wondering why anyone would pick me for @NSMCInternship. I applied in 2022 and was shocked to be accepted. I’ve grown thanks to many of you (@hswapnil @kidney_boy ), though I still feel like a newcomer. 😊 ✨

🙏 Grateful to be in this with @brian_rifkin #NephJC

[Joel M. Topf, MD FACP @kidney_boy]

Succession...#NephJC Style

https://t.co/okJib9gTFI

[Cristina Popa 🦋 @NephroSeeker]

#cryptoRecovery

[Cristina Popa 🦋 @NephroSeeker]

Big congratulations to me 🎉 Grateful to my mentor @TradeWithLilly for introducing me to trading and guiding me every step of the way. Hard work pays off. What had been a long time prayer and dream came together faster than I imagined. Contact CoachSophie if you’re interested.

[Brian Rifkin, MD @brian_rifkin]

I’m getting back to watercolor #ISNWCN
I forgot how hard it is to just let it do its thing 🌸

[International Society of Glomerular Disease @ISGDtweets]

🔑 clinical question:

Should therapy first target the cause of IgAN
or the mechanism of kidney injury?

This remains unresolved and likely depends on patient phenotype. 🧵(8)

#GlomerularDisease
#ISNWCN

[Sabine Karam @SabineKaram6]

In the setting of the alarming rise in worldwide disasters @ISNkidneycare @ASNKidney @ERAkidney are focusing on joint and impactful actions @ISNWCN #ISNWCN great talk by @Abualfaa from @AUB_Lebanon

[Fouad Chebib, MD, FASN @fouadchebib]

It was my honor to present the phase 1b trial results of Farabursen in ADPKD at WCN @ISNkidneycare

[Raquel Barba Teba 🦋 @DrBarbaTeba]

#ISNWCN
Spotlight session now with @NephroSeeker and @divyaa24: perspectives of a senior vs a junior on social media use for practice care.
Who speaks with authority online?
🫘Fast feedback from colleagues
🫘Updated information, mostly with sources cited

[Cristina Popa 🦋 @NephroSeeker]

#ISNWCN

[Nephrology Journal Club @NephJC]

The #ISNWCN has high trial impact clinical trials to celebrate latest and more successful results in our nephro world

To celebrate the joy of getting together, and to #NephItForward, we officially opened up the #NephJC Editorial Internship application

https://t.co/tAGg7SH8fG

[Dilushi Wijayaratne @Dilushiwijay]

Straight for the gurus @divyaa24 and @NephroSeeker
How to use social media appropriately to improve your practice and career in nephrology
#ISNWCN

[Dr. Divya Bajpai 🇮🇳 @divyaa24]

How to modify immunosuppressive on pregnancy #isnwcn

[Dr. Divya Bajpai 🇮🇳 @divyaa24]

Its important to differentiate preeclampsia from its close mimics

Anticoagulation is crucial even to be continued in post partum period
#isnwcn

[Cristina Popa 🦋 @NephroSeeker]

5/ and the presentation ends up with 3 quotes by Virchow 👉 medicine is social science; population disease arises from normalized harmful environments requiring political solutions
#ISNWCN

[Cristina Popa 🦋 @NephroSeeker]

A different presentation #ISNWCN

CKM syndrome reframes CKD as systemic cardiometabolic disease

Progression spans adiposity ➡️metabolic risk/CKD ➡️subclinical CVD ➡️overt CVD

Interactions extend beyond kidney–heart to liver, microbiome, inflammation, nutrition, and behavior

[Cristina Popa 🦋 @NephroSeeker]

4/ Addiction-driven industries (food, alcohol, nicotine, gambling, social media) shape behavior and environment, promoting obesity, inactivity, CKD and CVD

CKM reflects commercial determinants of health
#ISNWCN

[Cristina Popa 🦋 @NephroSeeker]

#ISNWCN

[Cristina Popa 🦋 @NephroSeeker]

@KateIsabelle24 underlining how sex is important for kidney health #ISNWCN

#flozins shifted CKD from dialysis inevitability to prevention
Sex differences matter: hormonal transitions alter kidney risk and treatment response; women underrepresented historically

[Cristina Popa 🦋 @NephroSeeker]

4/ Post-hoc SONAR: atrasentan reduced kidney events in women (HR 0.46) but not men (HR 0.83) #ISNWCN

Suggests sex-specific efficacy of endothelin blockade in diabetic CKD

📍Reinforces mandatory sex-disaggregated analyses in nephrology trials